G

Giant Biogene Holding Co Ltd
HKEX:2367

Watchlist Manager
Giant Biogene Holding Co Ltd
HKEX:2367
Watchlist
Price: 49.55 HKD -1.1%
Market Cap: 50.3B HKD
Have any thoughts about
Giant Biogene Holding Co Ltd?
Write Note

Net Margin
Giant Biogene Holding Co Ltd

39.7%
Current
40%
Average
3.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
39.7%
=
Net Income
1.8B
/
Revenue
4.5B

Net Margin Across Competitors

Country CN
Market Cap 51B HKD
Net Margin
40%
Country FR
Market Cap 176.4B EUR
Net Margin
15%
Country UK
Market Cap 113.2B GBP
Net Margin
11%
Country IN
Market Cap 5.6T INR
Net Margin
17%
Country UK
Market Cap 33.1B GBP
Net Margin
11%
Country DE
Market Cap 27.9B EUR
Net Margin
8%
Country US
Market Cap 23.3B USD
Net Margin
1%
Country JP
Market Cap 2.9T JPY
Net Margin
4%
Country IN
Market Cap 1.2T INR
Net Margin
-3%
Country IN
Market Cap 900.4B INR
Net Margin
14%
Country US
Market Cap 9.4B USD
Net Margin
12%

Profitability Report

View the profitability report to see the full profitability analysis for Giant Biogene Holding Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
39.7%
=
Net Income
1.8B
/
Revenue
4.5B
What is the Net Margin of Giant Biogene Holding Co Ltd?

Based on Giant Biogene Holding Co Ltd's most recent financial statements, the company has Net Margin of 39.7%.